These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1786646)

  • 21. Effects of the NMDA-antagonist, MK-801, on stress-induced alterations of dopamine dependent behavior.
    Mele A; Cabib S; Oliverio A
    Psychopharmacology (Berl); 1995 Feb; 117(3):313-7. PubMed ID: 7770607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute interactive effects of MK-801 and morphine on cortical EEG and EEG power spectra in rats.
    Haberny KA; Young GA
    Brain Res Bull; 1995; 36(4):325-31. PubMed ID: 7712191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.
    Fix AS; Horn JW; Wightman KA; Johnson CA; Long GG; Storts RW; Farber N; Wozniak DF; Olney JW
    Exp Neurol; 1993 Oct; 123(2):204-15. PubMed ID: 8405286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats.
    Löscher W; Hönack D; Fassbender CP
    Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory influence of morphinans on ictal and interictal EEG changes induced by cortical application of penicillin in rabbits: a comparative study with NMDA antagonists and pentobarbitone.
    Zeng YC; Pezzola A; Scotti De Carolis A; Sagratella S
    Pharmacol Biochem Behav; 1992 Oct; 43(2):651-6. PubMed ID: 1438506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
    Gilbert ME; Lasley SM
    Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of NMDA antagonist, MK-801 on spatial exploratory behavior in the rat].
    Sekiguchi R
    Shinrigaku Kenkyu; 1997 Jun; 68(2):88-94. PubMed ID: 9278960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of NMDA-receptor ligands on neocortical and hippocampal EEG activity of rat brain.
    Sharma AC; Kulkarni SK; Nayar U
    Indian J Exp Biol; 1991 Aug; 29(8):744-50. PubMed ID: 1837539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal neuronal responsiveness to NMDA agonists and antagonists in the adult rat neonatally treated with MK-801.
    Gorter JA; Veerman M; Mirmiran M
    Brain Res; 1992 Feb; 572(1-2):176-81. PubMed ID: 1351784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MK-801 subsensitivity following postweaning lead exposure.
    Cory-Slechta DA
    Neurotoxicology; 1995; 16(1):83-95. PubMed ID: 7603648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats.
    Ossowska G; Klenk-Majewska B; Szymczyk G
    J Physiol Pharmacol; 1997 Mar; 48(1):127-35. PubMed ID: 9098833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits.
    Thomas JD; Weinert SP; Sharif S; Riley EP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1218-25. PubMed ID: 9347082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation.
    Beart PM; Lodge D
    J Pharm Pharmacol; 1990 May; 42(5):354-5. PubMed ID: 1976785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of (+)SK&F 10047 and MK-801 on cortical spreading depression.
    Willette RN; Lysko PG; Sauermelch CF
    Brain Res; 1994 Jun; 648(2):347-51. PubMed ID: 7922552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NREM delta stimulation following MK-801 is a response of sleep systems.
    Campbell IG; Feinberg I
    J Neurophysiol; 1996 Dec; 76(6):3714-20. PubMed ID: 8985869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of NMDA receptors in neonatal cocaine-induced neurotoxicity.
    Huber JD; Darling SF; Park KK; Soliman KF
    Pharmacol Biochem Behav; 2001; 69(3-4):451-9. PubMed ID: 11509204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy.
    Yamamoto T; Yaksh TL
    Neurosci Lett; 1992 Jan; 135(1):67-70. PubMed ID: 1311824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential inhibition by NMDA antagonists of rapid tolerance to, and cross-tolerance between, ethanol and chlordiazepoxide.
    Khanna JM; Mihic SJ; Weiner J; Shah G; Wu PH; Kalant H
    Brain Res; 1992 Mar; 574(1-2):251-6. PubMed ID: 1638398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postnatal lead exposure and MK-801 sensitivity.
    Cory-Slechta DA
    Neurotoxicology; 1997; 18(1):209-20. PubMed ID: 9216003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.